PD-L1 is typically overexpressed in tumor cells, contributing to the tumor cells’ ability to avoid immune destruction; when it binds to PD-1 on T cells, they are deactivated and unable to destroy the cancer cells7. This evidence concerns the gene PDCD1 and cancer.